After the announcement made by the drug maker company has launched a novel anti-cancer drug, Palbociclib, in India for patients with advanced breast cancer. Sun...
Johnson & Johnson is targeting to manufacture up to three billion COVID-19 vaccine doses in 2022, the company’s chief scientific officer Dr. Paul Stoffels has...